MedTrace Logo

Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)

NCT01929824 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-09-30

No results posted yet for this study

Summary

This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).

Conditions

  • Eosinophilic Esophagitis

Interventions

OTHER

Oral Nitric Oxide testing

o Oral nitric oxide is measured by a breathing test where the participant will be seated in a chair and asked to breathe out into a small hand-held instrument for about 6 seconds.

Sponsors & Collaborators

Principal Investigators

  • Vivek Iyer, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-09-25
Completion
2019-09-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01929824 on ClinicalTrials.gov